Corrigendum to “Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients”. [Int J Antimicrob Agents 51 (2018) 594–600]

The authors regret that in the manuscript under the section 2.3 Study Protocol, the following is written: “This dose was either decreased or increased based on the patient's kidney function ( 200 mL/min: 24/3 g/24h)” This should read instead: “This dose was adapted based on the patient's kidney function ( 30 mL/min: 16/2 g/24 h) The authors would like to apologise for any inconvenience caused.